CLINICAL AND HISTOPATHOLOGICAL CORRELATION IN FIRST-TRIMESTER PREGNANCY LOSS:AN OBG–PATHOLOGY COLLABORATIVE STUDY
Main Article Content
Keywords
first-trimester pregnancy loss, miscarriage, products of conception, histopathology, chorionic villi, hydropic abortion, hydatidiform mole, p57, clinicopathological correlation
Abstract
Background: First-trimester pregnancy loss is common and represents a major clinical and emotional burden. Histopathological examination of products of conception (POC) can confirm intrauterine gestational tissue and occasionally identify clinically important entities such as hydatidiform mole, abnormal implantation-site trophoblast and other uncommon lesions.
Aim: To study the clinicopathological profile of women presenting with first-trimester pregnancy loss and to evaluate the histopathological spectrum of products of conception, with emphasis on clinical–pathological correlation.
Methods: A hospital-based observational study was done on 100 women with pregnancy loss up to 12 completed weeks who underwent uterine evacuation or submitted products of conception for histopathological examination. Demographic variables, gestational age, clinical presentation, ultrasound diagnosis, management and histopathological findings were recorded. Tissue was fixed in 10% neutral buffered formalin, routinely processed and stained with hematoxylin and eosin. Hydropic/molar-appearing specimens were considered for p57 immunohistochemistry as an ancillary test. Descriptive statistics and cross-tabulation were used.
Results: The cohort had a mean maternal age of 30.8 ± 6.2 years and mean gestational age of 8.3 ± 2.0 weeks. Vaginal bleeding was the commonest presenting symptom (84%), followed by lower abdominal pain/cramping (62%). Incomplete miscarriage was the most frequent clinical diagnosis (40%), followed by missed miscarriage (32%), anembryonic pregnancy loss (18%) and inevitable miscarriage (10%). Histopathology showed non-molar products of conception with chorionic villi and decidua in 75%, hydropic abortion in 10%, partial hydatidiform mole in 5%, complete hydatidiform mole in 2%, decidual tissue without chorionic villi in 7% and exaggerated implantation-site/placental-site trophoblastic change in 1%. Seven molar pregnancies were identified, including three not suspected before histopathological review.
Conclusion: Histopathological examination of POC provides useful clinicopathological correlation in first-trimester pregnancy loss and can occasionally identify unexpected molar or implantation-site pathology. Correlation with ultrasound and β-hCG is particularly important when chorionic villi are absent or hydropic villi are encountered.
References
2.Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194.
3.Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73:300–304.
4.American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–1111.
5.Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003;79:577–584.
6.National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE Guideline NG126. Updated 2007.
7.World Health Organization. Abortion care guideline. 2nd ed. Geneva: World Health Organization; 2008.
8.Jindal P, Regan L, Fourkala EO, Rai R, Moore G, Goldin RD, Sebire NJ. Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review. Hum Reprod. 2007;22:313–316.
9.Tasci Y, Dilbaz S, Secilmis O, Dilbaz B, Ozfuttu A, Haberal A. Routine histopathologic analysis of product of conception following first-trimester spontaneous miscarriages. J Obstet Gynaecol Res. 2005;31:579–582.
10.Ohayi SR, Onyishi NT. Routine histopathological analysis of the products of conception: Is there a value? Niger Med J. 2008;61:136–139.
11.Alsibiani SA. Value of histopathologic examination of uterine products after first-trimester miscarriage. Biomed Res Int. 2014;2014:863482.
12.Ronnett BM. Hydatidiform moles: ancillary techniques to refine diagnosis. Arch Pathol Lab Med. 2012;136:1495–1502.
13.Samadder A, Kar R. Utility of p57 immunohistochemistry in differentiating between complete mole, partial mole & non-molar or hydropic abortus. Indian J Med Res. 2013;145:133–137.
14.Hoffner L, Dunn J, Esposito N, Macpherson T, Surti U. p57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype. Hum Pathol. 2008;39:63–72.
15.Murphy KM, McConnell TG, Hafez MJ, Vang R, Ronnett BM. Molecular genetic analysis of complete hydatidiform moles and their mimics: diagnostic implications. Mod Pathol. 2007;20:114–121.
16.Khashaba M, Arafa M, Elsalkh E, Hemida R, Kandil W. Morphological features and immunohistochemical expression of p57Kip2 in early molar pregnancies and their relations to the progression to persistent trophoblastic disease. J Pathol Transl Med. 2012;51:381–387.
17.Murdoch JB, McConnell TG, Moinfar F, Ronnett BM. Comparison of FISH, p57 immunostaining, flow cytometry and digital image analysis for diagnosing molar and nonmolar products of conception. Am J Surg Pathol. 2010;34:149–158.
18.Sahoo S, et al. Chromosomal abnormalities in products of conception of first-trimester miscarriages detected by conventional cytogenetic analysis: review of 1000 cases. J Assist Reprod Genet. 2009;34:1339–1347.
19.ESHRE Guideline Group on RPL. ESHRE guideline: recurrent pregnancy loss. Human Reproduction Open. 2014.
20.Soltanghoraee H, et al. Histological evaluation of products of conception: who benefits from it? Fetal Pediatr Pathol. 2013

